BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31653542)

  • 1. [Ductal carcinoma in situ in 2019: Diagnosis, treatment, prognosis].
    Cutuli B
    Presse Med; 2019 Oct; 48(10):1112-1122. PubMed ID: 31653542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
    Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
    Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies.
    Silverstein MJ; Parker R; Grotting JC; Cote RJ; Russell CA
    J Am Coll Surg; 2001 Feb; 192(2):196-214. PubMed ID: 11220720
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient education. Ductal carcinoma in situ.
    NSW Breast Cancer Institute
    Aust Fam Physician; 2005 Nov; 34(11):955. PubMed ID: 16299631
    [No Abstract]   [Full Text] [Related]  

  • 8. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is sentinel node biopsy necessary in conservatively treated DCIS?
    Julian TB; Land SR; Fourchotte V; Haile SR; Fisher ER; Mamounas EP; Costantino JP; Wolmark N
    Ann Surg Oncol; 2007 Aug; 14(8):2202-8. PubMed ID: 17534687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards optimal management of ductal carcinoma in situ of the breast.
    Mokbel K
    Eur J Surg Oncol; 2003 Mar; 29(2):191-7. PubMed ID: 12633565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
    Cutuli B; Lemanski C; De Lafontan B; Chauvet MP; De Lara CT; Mege A; Fric D; Richard-Molard M; Mazouni C; Cuvier C; Carre A; Kirova Y
    Clin Breast Cancer; 2020 Apr; 20(2):e164-e172. PubMed ID: 31780381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of ductal carcinoma in situ.
    Khan A; Newman LA
    Curr Treat Options Oncol; 2004 Apr; 5(2):131-44. PubMed ID: 14990207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ of the breast - Long term results from a twenty-year cohort.
    Co M; Kwong A
    Cancer Treat Res Commun; 2018; 14():17-20. PubMed ID: 30104003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ--management update.
    Stuart K; Boyages J; Brennan M; Ung O
    Aust Fam Physician; 2005 Nov; 34(11):949-54. PubMed ID: 16299630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
    Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
    [No Abstract]   [Full Text] [Related]  

  • 19. Current perspectives of treatment of ductal carcinoma in situ.
    Estévez LG; Alvarez I; Seguí MÁ; Muñoz M; Margelí M; Miró C; Rubio C; Lluch A; Tusquets I
    Cancer Treat Rev; 2010 Nov; 36(7):507-17. PubMed ID: 20462701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
    Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
    Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.